Skip to main content

Atrial Fibrillation News

Left Atrial Appendage Occlusion
11/02/2026
New findings from the randomized SIMPLAAFY trial suggest that less intensive antithrombotic therapy following left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro LAAC Device can reduce the risk of clinically-relevant bleeding...
New findings from the randomized SIMPLAAFY trial suggest that less intensive antithrombotic therapy following left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro LAAC Device can reduce the risk of clinically-relevant bleeding...
New findings from the randomized...
11/02/2026
Cath Lab Digest
Left Atrial Appendage Occlusion
11/02/2026
Late-breaking one-year VERITAS study results were presented at TCT 2026; data show the device achieved high closure rates of the left atrial appendage (LAA) and a low incidence of stroke.
Late-breaking one-year VERITAS study results were presented at TCT 2026; data show the device achieved high closure rates of the left atrial appendage (LAA) and a low incidence of stroke.
Late-breaking one-year VERITAS...
11/02/2026
Cath Lab Digest
Wearable AF Screening
05/08/2026
Laura Simson, MA
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial...
05/08/2026
Journal of Invasive Cardiology
Press Release
04/24/2026
HRS Press Release CHICAGO, IL, APRIL 24, 2026 – The Heart Rhythm Society announced the first analysis of its Centers of Excellence Optimal Management Pathways for Atrial Fibrillation Specialty Services Early...
HRS Press Release CHICAGO, IL, APRIL 24, 2026 – The Heart Rhythm Society announced the first analysis of its Centers of Excellence Optimal Management Pathways for Atrial Fibrillation Specialty Services Early...
HRS Press...
04/24/2026
EP Lab Digest
GLP-1 Medications
04/23/2026
Researchers conducted a single-center retrospective study of 13,034 patients who initiated GLP-1-RA therapy between January 2020 and May 2024.
Researchers conducted a single-center retrospective study of 13,034 patients who initiated GLP-1-RA therapy between January 2020 and May 2024.
Researchers conducted a...
04/23/2026
Cath Lab Digest
ACC 2026
03/30/2026
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of...
03/30/2026
Cath Lab Digest
PAD + AF
11/11/2025
“This is a stark reminder that PAD is not just a limb-threatening disease – it’s a marker of widespread atherosclerosis,” said Viet Le, DMSc, MPAS, PA-C, an advanced practice clinician and cardiovascular researcher at Intermountain Health and...
“This is a stark reminder that PAD is not just a limb-threatening disease – it’s a marker of widespread atherosclerosis,” said Viet Le, DMSc, MPAS, PA-C, an advanced practice clinician and cardiovascular researcher at Intermountain Health and...
“This is a stark reminder that...
11/11/2025
Cath Lab Digest
Mitral TEER & AFIB
07/23/2025
“AF is a powerful risk marker that we need to take into consideration when planning and performing these procedures,” says corresponding author Stamatios Lerakis, MD, PhD. M-TEER was equally successful in both groups (AF and no AF). However,...
“AF is a powerful risk marker that we need to take into consideration when planning and performing these procedures,” says corresponding author Stamatios Lerakis, MD, PhD. M-TEER was equally successful in both groups (AF and no AF). However,...
“AF is a powerful risk marker...
07/23/2025
EP Lab Digest
Press Release
04/23/2025
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS)...
04/23/2025
EP Lab Digest
Press Release
03/31/2025
ESC Press Release Vienna, Austria- 31 March 2025 - New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation (AF) increases the risk of future...
ESC Press Release Vienna, Austria- 31 March 2025 - New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation (AF) increases the risk of future...
ESC Press Release Vienna,...
03/31/2025
EP Lab Digest